Preferences for oral anticoagulant medications for managing atrial fibrillation

Factors Influencing Oral Anticoagulant Prescribing Practices for Atrial Fibrillation

Novel oral anticoagulants in atrial fibrillation: which novel oral anticoagulant for which patient?

Atrial fibrillation is the most common rhythm disorder and represents a major public health problem because it carries an increased risk of arterial thromboembolism and ischemic stroke. Current european society of cardiology guidelines recommend to stratify atrial fibrillation patients according to the CHA2DS2-VASc score and to administer anticoagulation, preferably with novel oral anticoagulan...

Practical aspects of new oral anticoagulant use in atrial fibrillation.

Dabigatran, a direct thrombin inhibitor and 2 factor Xa inhibitors, rivaroxaban and apixaban, are target-specific oral anticoagulants (TSOACs) approved for prevention of stroke or systemic embolism in patients with nonvalvular atrial fibrillation (AF). Published data suggest that all 3 agents are at least as efficacious as dose‑adjusted warfarin in stroke prevention. Because of their greater sp...

Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project

Corresponding authors: Prof. Gregory Y.H. Lip University of Birmingham Centre for Cardiovascular Sciences City Hospital Birmingham, United Kingdom E-mail: [email protected] Prof. Kui Hong Cardiovascular Department the Second Affiliated Hospital of Nanchang University Nanchang, China Phone: +44 121 507 5080 Fax: +44 121 554 4083 E-mail: [email protected] 1 Cardiovascular Department, the Secon...

Managing oral anticoagulant therapy.

2001;119;22S-38S Chest Leon Poller, Alan Jacobson, Daniel Deykin and David Matchar Jack Ansell, Jack Hirsh, James Dalen, Henry Bussey, David Anderson, Managing Oral Anticoagulant Therapy l.html http://chestjournal.chestpubs.org/content/119/1_suppl/22S.ful and services can be found online on the World Wide Web at: The online version of this article, along with updated information ISSN:0012-3692 ...